Skip to main content
. 2021 Jan 1;11(2):540–554. doi: 10.7150/thno.49517

Figure 10.

Figure 10

HT40 therapy enhanced infiltration of T cells in the treated and distant untreated (abscopal) tumors. (A & B) Representative examples of the immunohistochemical staining of treated (A) and untreated tumor (B) sections for CD3 marker. Both treated and untreated tumors from HT40 cohort showed an increased population of CD3+T cells in the tumor (arrows) compared to monotherapies. Scale bar: 100μm.